EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
1.13.99.1 | cysteine | best activation system: 1 mM Fe(II) and 2 mM cysteine | Sus scrofa | |
1.13.99.1 | cysteine | DL-penicillamine | Sus scrofa | |
1.13.99.1 | cysteine | either reagent alone gives very little activation | Sus scrofa | |
1.13.99.1 | cysteine | L-cysteine can be replaced by D-cysteine | Sus scrofa | |
1.13.99.1 | cysteine | or gamma-L-glutamyl-L-cysteine | Sus scrofa | |
1.13.99.1 | D-cysteine | best activation system: 1 mM Fe(II) and 2 mM cysteine, L-cysteine can be replaced by D-cysteine, DL-penicillamine or gamma-L-glutamyl-L-cysteine | Sus scrofa | |
1.13.99.1 | DL-Penicillamine | best activation system: 1 mM Fe(II) and 2 mM cysteine, L-cysteine can be replaced by D-cysteine, DL-penicillamine or gamma-L-glutamyl-L-cysteine | Sus scrofa | |
1.13.99.1 | gamma-L-glutamyl-L-cysteine | best activation system: 1 mM Fe(II) and 2 mM cysteine, L-cysteine can be replaced by D-cysteine, DL-penicillamine or gamma-L-glutamyl-L-cysteine | Sus scrofa |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.13.99.1 | 5,5'-dithiobis(2-nitrobenzoate) | - |
Sus scrofa | |
1.13.99.1 | 8-hydroxyquinoline | - |
Sus scrofa | |
1.13.99.1 | ADP | - |
Sus scrofa | |
1.13.99.1 | alpha,alpha'-bipyridine | - |
Sus scrofa | |
1.13.99.1 | alpha-ketoglutarate | - |
Sus scrofa | |
1.13.99.1 | ATP | - |
Sus scrofa | |
1.13.99.1 | azide | - |
Sus scrofa | |
1.13.99.1 | Barbital | - |
Sus scrofa | |
1.13.99.1 | Cu2+ | - |
Sus scrofa | |
1.13.99.1 | cyanide | - |
Sus scrofa | |
1.13.99.1 | diethyldithiocarbamate | - |
Sus scrofa | |
1.13.99.1 | EDTA | - |
Sus scrofa | |
1.13.99.1 | Fe3+ | - |
Sus scrofa | |
1.13.99.1 | ferricyanide | - |
Sus scrofa | |
1.13.99.1 | ferrocyanide | - |
Sus scrofa | |
1.13.99.1 | glyoxylate | - |
Sus scrofa | |
1.13.99.1 | GTP | - |
Sus scrofa | |
1.13.99.1 | H2O2 | - |
Sus scrofa | |
1.13.99.1 | Hg2+ | - |
Sus scrofa | |
1.13.99.1 | iodoacetate | - |
Sus scrofa | |
1.13.99.1 | N-ethylmaleimide | slight | Sus scrofa | |
1.13.99.1 | o-phenanthroline | - |
Sus scrofa | |
1.13.99.1 | oxalacetate | - |
Sus scrofa | |
1.13.99.1 | oxalate | - |
Sus scrofa | |
1.13.99.1 | p-chloromercuribenzoate | - |
Sus scrofa | |
1.13.99.1 | Phenobarbital | - |
Sus scrofa | |
1.13.99.1 | pyruvate | - |
Sus scrofa | |
1.13.99.1 | Sodium borohydride | - |
Sus scrofa | |
1.13.99.1 | UDP | - |
Sus scrofa | |
1.13.99.1 | UTP | - |
Sus scrofa | |
1.13.99.1 | xanthurenic acid | - |
Sus scrofa |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.13.99.1 | 0.2 | - |
Inositol | with Fe(II) and quinolinic acid as activators | Sus scrofa | |
1.13.99.1 | 5 | - |
Inositol | with Fe(II) and L-cysteine as activators | Sus scrofa |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
1.13.99.1 | Fe2+ | either reagent alone gives very little activation | Sus scrofa | |
1.13.99.1 | Fe2+ | no other metal ion can replace Fe(II) | Sus scrofa | |
1.13.99.1 | Fe2+ | 1 mM Fe(II) and 2 mM cysteine | Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.13.99.1 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.13.99.1 | kidney | - |
Sus scrofa | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.99.1 | myo-inositol + O2 | highly specific for myo-inositol | Sus scrofa | D-glucuronate + H2O | - |
? |
EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.13.99.1 | 34 | - |
inactivation during 15 min assay | Sus scrofa |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.13.99.1 | 6 | - |
- |
Sus scrofa |